MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Molecular mechanisms of GCH1-associated Parkinson’s disease

    J. Terbeek, W. Vandenberghe (Leuven, Belgium)

    Objective: To unravel the molecular mechanisms by which loss of GCH1 function enhances the risk of Parkinson´s disease (PD). Background: Loss-of-function mutations in GCH1 are…
  • 2018 International Congress

    Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism

    E. Mäkinen, J. Joutsa, E. Jaakkola, T. Noponen, J. Johansson, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The primary aim of the study was to investigate if any individual motor sign could be used clinically to predict striatal dopamine deficiency. Secondary…
  • 2018 International Congress

    Characteristics of brain mri in patient with Parkinson’s disease

    K. Merryn, A. Shahab, R. Faisal, S. Marisdina, E. Bahar (Palembang, Indonesia)

    Objective: To investigate the characteristics and brain MRI findings in patient with Parkinson’s Disease Background: Parkinson's Disease is a chronic, progressive neurodegenerative disease that is…
  • 2018 International Congress

    Evaluation of bradykinesia in Parkinson’s disease using a computerised evolutionary algorithm

    R. Newby, S. Muhamed, P. Kempster, J. Alty, S. Jamieson, J. Cosgrove, S. Smith (Leeds, United Kingdom)

    Objective: Application of a computerised algorithm to kinematic motor recordings to distinguish parkinsonian bradykinesia from normal movement. Background: Bradykinesia, the only obligatory physical sign for…
  • 2018 International Congress

    Sexual Dysfunction in Women with Parkinson’s Disease

    A. Hannoun, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To assess the prevalence and severity of sexual dysfunction (SD) in women with Parkinson’s Disease (PD) in comparison to general population (GP), highlight the…
  • 2018 International Congress

    Pain is correlated with other motor and non-motor symptom in Parkinson’s disease

    Y. Liu, X.Y. Zhu, X.J. Zhang, S.L. Yang, T.Y. Feng, Y.C. Wu (Shanghai, China)

    Objective: Study pain occurrence and appearance in Parkinson’s disease (PD), and its relationship with other motor and non-motor symptoms like constipation and footsteps. Background: The…
  • 2018 International Congress

    Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

    G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

    Objective: To provide the psychometric validation of the French MDT-PD in the Luxembourgish multilingual population. Background: The MDT-PD, developed and validated in German [1], is…
  • 2018 International Congress

    Stigma and communication in people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…
  • 2018 International Congress

    B lymphocytes may be protective in early Parkinson’s disease and in an animal model of dopaminergic cell death

    K. Scott, C. Williams-Gray, R. Wijeyekoon, S. Hayat, K. Hall, P. Tyers, R. Mathews, R. Barker, M. Clatworthy (Cambridge, United Kingdom)

    Objective: To investigate B lymphocyte phenotype and function in human PD and in an animal model of disease. Background: The clinical course in Parkinson’s disease…
  • 2018 International Congress

    Red cell distribution with levels in Parkinson’s disease patients

    G. Ozgen Kenangil, B.C. Ari, F. Altuntas Kaya, M. Demir, F. Mayda Domac (Istanbul, Turkey)

    Objective: Parkinson’s Disease is a neurodegenerative disorder caused by oxidative stress, protein changes and mitochondrial disfunction. Lately, it has been suggested that inflammatory cytokine levels…
  • « Previous Page
  • 1
  • …
  • 231
  • 232
  • 233
  • 234
  • 235
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley